copper intrauterine devices
Summary: Intrauterine contraceptive devices that depend on the release of metallic copper.
Publications161 found, 100 shown here
- [The role of copper-releasing intrauterine device or levonorgestrel-releasing intrauterine system on uterine bleeding and iron status (prospective study of 8 years)]F Imperato
II Facolta di Medicina e Chirurgia, Istituto di Ostetricia e Ginecologia, Universita degli Studi La Sapienza, Rome, Italy
Minerva Ginecol 54:271-8. 2002..The authors evaluated the effect of copper surface area on uterine bleeding...
- IUDs: which device?Jo Dennis
Abacus Centres for Family Planning and Reproductive Health, Liverpool, UK
J Fam Plann Reprod Health Care 28:61-8. 2002
- Mechanisms of action of intrauterine devices: update and estimation of postfertilization effectsJoseph B Stanford
Department of Family and Preventive Medicine, University of Utah Health Research Center, Salt Lake City 84108, USA
Am J Obstet Gynecol 187:1699-708. 2002....
- Use of copper intrauterine devices and the risk of tubal infertility among nulligravid womenD Hubacher
Family Health International, Research Triangle Park, NC 27709, USA
N Engl J Med 345:561-7. 2001..The concern that IUDs that contain copper--currently the most commonly used type--may increase the risk of infertility in nulligravid women has limited the use of this highly effective method of birth control...
- Outcomes at 1 year for the first 200 patients fitted with GyneFix at Margaret Pyke CentreT Masters
Avon Brook, Bristol, UK
Eur J Contracept Reprod Health Care 7:65-70. 2002..However, they are perhaps not as good as had been anticipated for this revolutionary new intrauterine implant. Possible reasons for this are explored...
- [Inconveniences and complications after insertion of IUDs by general practitioners]Jytte Rothmann Johansen
København Universitet, Institut for Folkesundhedsvidenskab, Afdeling for Almen Medicin, København
Ugeskr Laeger 166:3190-4. 2004
- The intrauterine device: rethinking old paradigmsKatherine W Morgan
University of Utah College of Nursing, 10 South 2000 East, Salt Lake City, UT 84112, USA
J Midwifery Womens Health 51:464-70. 2006..In light of this data, the IUD should be made available to women at low-risk for sexually-transmitted infections and should not be denied to women on the basis of parity or marital status...
- Attitudes of Israeli gynecologists towards the levonorgestrel-releasing intrauterine system: a questionnaire surveyA Ben-Haroush
Department of Obstetrics and Gynecology, Rabin Medical Center, Petach Tiqva and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
Eur J Contracept Reprod Health Care 9:29-33. 2004..In addition, physician knowledge of patient satisfaction with the device was evaluated...
- [Intrauterine devices in general practice: a prospective study of 300 insertions]H Marret
Département de gynécologie obstétrique, Medecine Foetale et Reproduction Humaine, Hopital Bretonneau, 2, boulevard Tonnelle, 37044 Tours Cedex 1, France
J Gynecol Obstet Biol Reprod (Paris) 31:465-70. 2002To assess the effectiveness of management practices of copper intrauterine devices (IUD) in general medicine.
- Intrauterine contraception: the role of general practitioners in four Dutch general practicesAnnika A G Vos
Women s Studies in Medicine, Department of General Practice, University of Nijmegen, Nijmegen, The Netherlands
Contraception 69:283-7. 2004..General practitioners clearly follow their own opinions about inserting IUD in nulliparous women. Currently, general practitioners are prescribing more Multiload Cu 375 IUDs and levonorgestrel-releasing IUDs...
- Clinical outcomes of early postplacental insertion of intrauterine contraceptive devicesSevki Celen
Zekai Tahir Burak Women Health Education and Research Hospital, Ankara, Turkey
Contraception 69:279-82. 2004..To assess the efficacy, safety and, thus, advantages and disadvantages, of early postplacental intrauterine device (IUD) insertion...
- Problems in the conduct and analysis of "A comparative randomized study of three different IUDs in nulliparous Mexican women"Irving Sivin
Contraception 69:259-60. 2004
- Ectopic pregnancy among non-medicated and copper-containing intrauterine device users: a 10-year follow-upSanjay Ganacharya
Department of Obstetrics and Gynecology, Medical and Health Science Center, University of Debrecen, P O Box 37, Nagyerdei krt 98, H 4012 Debrecen, Hungary
Eur J Obstet Gynecol Reprod Biol 111:78-82. 2003..To compare ectopic pregnancy (EP) rates among users of non-medicated and copper-containing IUDs...
- Insertion of intrauterine devices: a comparison of experience with Mirena and Multiload Cu 375 during post-marketing monitoring in New ZealandMira Harrison-Woolrych
Intensive Medicines Monitoring Programme, Department of Preventive and Social Medicine, University of Otago, Dunedin, New Zealand
N Z Med J 116:U538. 2003..To compare the incidence of reported insertion problems with the levonorgestrel-releasing intrauterine device (Mirena) with that of the copper device Multiload Cu 375...
- Randomized comparison of levonorgestrel- and copper-releasing intrauterine systems immediately after abortion, with 5 years' follow-upPaivi Pakarinen
Steroid Research Laboratory, Biochemistry, Institute of Biomedicine, Biomedicum, University of Helsinki, Helsinki, Finland
Contraception 68:31-4. 2003..Mirena was more effective and the rate of adverse events was lower than with NovaT. Special attention should be paid to the insertion procedure when carried out at the time of abortion...
- [Effects of intrauterine contraceptive device on expression of vascular endothelial growth factor, kinase insert domain-containing receptor and microvessel density in endometrium]Zhi Min Xin
Reproductive Medical Center, First Affiliated Hospital, Zhengzhou University, Zhengzhou 450052, China
Zhonghua Fu Chan Ke Za Zhi 39:771-5. 2004....
- Effect of a levonorgestrel intrauterine system on women with type 1 diabetes: a randomized trialSvetlana Rogovskaya
Research Center of Obstetrics, Gynecology, and Perinatology, Russian Academy of Medical Science, Moscow, Russia
Obstet Gynecol 105:811-5. 2005..To examine the effect of the levonorgestrel-releasing intrauterine system on glucose metabolism in diabetic women...
- The 'frameless' intrauterine system for long-term, reversible contraception: a review of 15 years of clinical experienceDirk Wildemeersch
Contrel Research, Technology Park, University of Ghent, Belgium
J Obstet Gynaecol Res 29:164-73. 2003..The development of the 'frameless' intrauterine system (IUS) is a response to the growing need to develop high-performing, long-acting, reversible, and acceptable contraceptives with a high continuation of use...
- Intrauterine contraception: an updateR K Bhathena
Department of Obstetrics and Gynaecology, B D Petit Parsee General and Masina Hospitals, Bombay, India
J Obstet Gynaecol 28:262-5. 2008
- Options for intrauterine contraceptionHeidi Collins Fantasia
William F Connell School of Nursing, Boston College, Chestnut Hill, MA, USA
J Obstet Gynecol Neonatal Nurs 37:375-83. 2008..A greater understanding of the benefits and limitations of these two contraceptive options will assist women's health care providers to better meet the family planning needs of their patients...
- [Non hormonal contraception]Geoffroy Robin
Service de gynécologie médicale et médecine du couple, Hopital Jeanne de Flandre, CHRU de Lille, 59037 Lille
Rev Prat 58:29-40. 2008Excluded hormonal contraceptives, there are non hormonal means of contraception. Among them, copper intrauterine devices (IUD) are very efficient...
- IUD In Situ?Colleen Dy
J Obstet Gynaecol Can 30:107-8. 2008
- Effect of different contraceptive methods on the oxidative stress status in women aged 40 48 years from the ELAN study in the province of Liege, BelgiumJ Pincemail
Department of Cardiovascular Surgery, University of Liege, CHU Sart Tilman, 4000 Liege, Belgium
Hum Reprod 22:2335-43. 2007..Among conditions known to influence oxidative stress, the use of oral contraception (OC) in women has been a matter of ongoing discussion...
- New frameless and framed intrauterine devices and systems - an overviewDirk Wildemeersch
Contrel Research, Technology Park, University of Ghent, 9000 Ghent, Belgium
Contraception 75:S82-92. 2007..In some women, the use of misoprostol 400 microg, 3 h prior to fitting of the IUD/IUS, may be useful to dilate the cervical canal. The popularity of the IUD could be much improved if attention is given to this aspect of IUD insertion...
- Cochrane systematic reviews of IUD trials: lessons learnedDavid A Grimes
Family Health, International, P O Box 13950, Research Triangle Park, NC 27796, USA
Contraception 75:S55-9. 2007..Intrauterine devices (IUDs) are the most widely used reversible contraceptives in the world today, and decisions about their use should reflect the best available evidence...
- A randomized trial on the clinical performance of Nova T380 and Gyne T380 Slimline copper IUDsTommy Haugan
Department of Epidemiology, SINTEF Health Research, N 7465 Trondheim, Norway
Contraception 75:171-6. 2007The objective of this open randomized study was to compare the clinical performance of Nova T380 and Gyne T380 Slimline copper intrauterine devices (IUDs).
- Surgical management of intra-abdominal mislocated intrauterine devicesMahmut T Ozgun
Department of Obstetrics and Gynecology, Faculty of Medicine, Gevher Nesibe Hospital, Erciyes University, 38039 Kayseri, Turkey
Contraception 75:96-100. 2007..We report on our experience in surgical treatment of patients with intra-abdominal intrauterine devices (IUDs)...
- Contraception for the older woman: an updateR K Bhathena
Department of Obstetrics and Gynaecology, Petit Parsee General and Masina Hospitals, Bombay, India
Climacteric 9:264-76. 2006..The woman should be provided with individualized advice so that she has a choice between the newer, effective, largely safe, reversible methods and sterilization...
- [Weight variation in users of the levonorgestrel-releasing intrauterine system, of the copper IUD and of medroxyprogesterone acetate in Brazil]Daniela Angerame Yela
Departamento de Obstetricia e Ginecologia, Faculdade de Medicina, Universidade Estadual de Campinas UNICAMP, Campinas, Brazil
Rev Assoc Med Bras 52:32-6. 2006....
- Insertion of an intrauterine contraceptive device after induced or spontaneous abortion: a review of the evidenceN L Stanwood
Robert Wood Johnson Clinical Scholars Program, University of North Carolina School of Medicine, Chapel Hill, USA
BJOG 108:1168-73. 2001..Immediate insertion may have a higher expulsion rate than delayed insertion. However, these risks may be outweighed by the benefit of immediate contraception...
- TCu 380A IUD: a reversible permanent contraceptive method in women over 35 years of ageLuis Bahamondes
Human Reproduction Unit, Department of Obstetrics and Gynecology, School of Medicine, Universidade Estadual de Campinas UNICAMP, Campinas 13084 971, Brazil
Contraception 72:337-41. 2005..The objective of the study was to evaluate the performance of the TCu 380A IUD in women who had been using the device for more than 10 years and who were 35 years of age or more on completion of the 10th year of IUD use...
- Extending the time limit for starting the Yuzpe regimen of emergency contraception to 120 hoursCharlotte Ellertson
Ibis Reproductive Health, Cambridge, Massachusetts 02138, USA
Obstet Gynecol 101:1168-71. 2003..The purpose of this study was to determine whether the window for emergency hormonal contraception can be extended to 120 hours...
- State-of-the-art of non-hormonal methods of contraception: III. Intrauterine devicesIrving Sivin
Population Council, New York, NY10065, USA
Eur J Contracept Reprod Health Care 15:96-112. 2010..Yet other research lines indicate noncontraceptive benefits of copper intrauterine devices in protecting against endometrial cancer, and favourable risk-benefit analyses of IUD use by women at ..
- Efficacy of contraceptive methods: A review of the literatureDiana Mansour
New Croft Centre, Newcastle upon Tyne, UK
Eur J Contracept Reprod Health Care 15:4-16. 2010..To provide a comprehensive and objective summary of contraceptive failure rates for a variety of methods based on a systematic review of the literature...
- Copper hypersensitivity: dermatologic aspects--an overviewJurij J Hostynek
Euromerican Technology Resources, Inc, Lafayette, California 94549, USA
Rev Environ Health 18:153-83. 2003..systemic allergic reactions (SAR) and contact stomatitis (STO), but considering the widespread use of copper intrauterine devices (IUDs) and the importance of copper in coinage, items of personal adornment and industry, unambiguous ..
- The 'tail' of a missing intrauterine contraceptive deviceHanan Ismail
Career Grade Trainee in Family Planning and Reproductive Health, Graingerville Clinic, Newcastle General Hospital, Newcastle upon Tyne, UK
J Fam Plann Reprod Health Care 28:96-7. 2002..Accurate ultrasound examination can ensure the avoidance of unnecessary x-rays or surgery. The case also acts as a reminder that a missing thread of an IUD does not imply that the device is misplaced...
- The local progestational effect of the levonorgestrel-releasing intrauterine system: a sonographic and Doppler flow studyY Zalel
Department of Obstetrics and Gynecology, The Chaim Sheba Medical Center, affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Tel Hashomer, Israel
Hum Reprod 17:2878-80. 2002..We aimed to evaluate the effect of the levonorgestrel-releasing intrauterine system (LNG-IUS) on the uterine vasculature and the endometrium...
- Efficacy of a mini version of the frameless GyneFix intrauterine system (IUS) with effective copper surface area of 200 mm2. email@example.comDirk Wildemeersch
Contrel Research, Ghent, Belgium
Contraception 66:237-41. 2002..This is made possible by anchoring the active contraceptive substance to the fundus of the uterus. The fact that 100% of the copper surface area of the frameless IUS is available for copper release is an additional advantage...
- Intrauterine device use among women with ovarian cancer: a systematic reviewLauren B Zapata
Centers for Disease Control and Prevention, Atlanta, GA, 30341, USA
Contraception 82:38-40. 2010..Fertility-sparing treatment may be an option for women with early stage ovarian cancer and certain tumor types. This systematic review evaluated the evidence on the safety of intrauterine device (IUD) use by women with ovarian cancer...
- Alterations in copper homeostasis and oxidative stress biomarkers in women using the intrauterine device TCu380ANathalie Arnal
INIBIOLP Instituto de Investigaciones Bioquímicas de La Plata, CCT La Plata, CONICET UNLP, Catedra de Bioquimica y Biologia Molecular, Facultad de Ciencias Medicas, Universidad Nacional de La Plata, La Plata, Argentina
Toxicol Lett 192:373-8. 2010..We concluded that the use of Cu-IUDs for more than 2 consecutive years should be avoided in order to prevent oxidative damage...
- Removal of copper-bearing IUDs in asymptomatic patients. ReplyJyoti Jatti
J Fam Plann Reprod Health Care 34:136. 2008
- Uterovesical fistula and bladder stones following bladder penetration by a perforating intrauterine contraceptive deviceA M E Nwofor
Department of Surgery, Nnamdi Azikiwe University Teaching Hospital, Nnewi, Nigeria
J Obstet Gynaecol 23:683-4. 2003
- Follow-up visits after IUD insertion. Are more better?D Hubacher
Family Health International, Research Triangle Park, NC 27709, USA
J Reprod Med 44:801-6. 1999..To determine whether frequent follow-up visits for intrauterine device (IUD) users prevents the development of pelvic inflammatory disease (PID)...
- Does over-exposure to copper ions released from metallic copper induce cytotoxic and genotoxic effects on mammalian cells?Claudia A Grillo
Instituto de Investigaciones Fisicoquimicas Teoricas y Aplicadas INIFTA, CCT CONICET La Plata, Facultad de Ciencias Exactas, Departamento de Quimica, Universidad Nacional de La Plata, La Plata, Argentina
Contraception 81:343-9. 2010..This work is focused on the assessment of the possible cyto- and genotoxic effects of different concentrations of copper ions released from metallic copper on mammalian cells in vitro...
- Erosion of an intrauterine contraceptive device through the bladder wall causing calculus: management and review of the literatureMahmoud Mustafa
Urology Department, Osmaniye State Hospital, Osmaniye, Turkey
Urol Int 82:370-1. 2009..A 46-year-old women is described in whom intravesical migration of the intrauterine device was complicated by bladder stone formation. Endoscopic management was applied with an excellent outcome...
- Transuterine migration as a complication of intrauterine contraceptive devices: six case reportsY A Tuncay
SSK Goztepe Educational Hospital, Clinic of Obstetrics and Gynecology, Istanbul, Turkey
Eur J Contracept Reprod Health Care 9:194-200. 2004..Although an IUD is an effective contraceptive method, the migration of one is a rare but serious complication. The aim of this report is to emphasize the management and therapy of this complication...
- Comparison of efficacy and complications of IUD insertion in immediate postplacental/early postpartum period with interval period: 1 year follow-upKafiye Eroğlu
Department of Obstetrics and Women s Health Nursing, School of Nursing, Hacettepe, University, 06100 Ankara, Turkey
Contraception 74:376-81. 2006..This study aimed to compare immediate postplacental (IPP) and early postpartum (EP) intrauterine device (IUD) insertions with interval (INT) IUD insertions with respect to efficacy and complications...
- Contraception and treatment in the perimenopause with a novel "frameless" intrauterine levonorgestrel-releasing drug delivery system: an extended pilot studyD Wildemeersch
Contrel Research, Technology Park Zwijnaarde, Ghent, Belgium
Contraception 66:93-9. 2002....
- Peritoneal abscess resulting from a translocated copper intrauterine deviceJyoti Jatti
Department of Gynaecology, Gloucestershire Royal Hospital, Gloucester, UK
J Fam Plann Reprod Health Care 33:57-8. 2007
- Comparison of the release behaviors of cupric ions from metallic copper and a novel composite in simulated body fluidJuan Li
State Key Laboratory of Mould Technology, College of Materials Science and Engineering, Huazhong University of Science and Technology, Wuhan 430074, People s Republic of China
J Biomed Mater Res B Appl Biomater 85:172-9. 2008..In view of the earlier results, this novel copper-containing composite might serve as a potential substitute for conventional materials of IUDs in the future...
- [Use of 3-dimensional ultrasound for assessment of intrauterine device position]I Hösli
Geburtshilfe und Schwangerschaftsmedizin, Universitats Frauenklinik Basel
Ultraschall Med 22:75-80. 2001..The purpose of our prospective study was to assess the accuracy of measuring and visualizing different types of IUDs with three dimensional ultrasound (3D) and two dimensional ultrasound (2D)...
- Emergency contraceptive options available for adolescentsVishal Gupta
Pediatric Research in Emergency Therapeutics Program, Hospital for Sick Children, Toronto, Ontario, Canada
Can Fam Physician 52:1219-20. 2006..While many teenagers are unaware of these options, this armamentarium is very effective if used early after coitus and when further sexual activity is avoided for a few days...
- Local tissue effects of copper-containing intrauterine devicesKalman Patai
Fertil Steril 80:1281-3. 2003
- Sonographic and Doppler flow characteristics of levonorgestrel and copper-releasing intrauterine devicesYaron Zalel
Department of Obstetrics and Gynecology, Sheba Medical Center, Tel Hashomer, Israel
MedGenMed 5:38. 2003
- Contraceptive use among solid organ transplant patients: a systematic reviewMelissa E Paulen
Centers for Disease Control and Prevention, Atlanta, GA 30341, USA
Contraception 82:102-12. 2010..Women undergoing solid organ transplantation are advised to avoid pregnancy for up to 24 months following transplant surgery...
- Asymptomatic ileal perforation of an intrauterine deviceS Disu
Department of Obstetrics and Gynaecology, Elizabeth Garrett Anderson Hospital, University College London Hospitals NHS Trust, Huntley Street, London, WC1E 6DH, UK
Arch Gynecol Obstet 269:230-1. 2004..The apparent insertion of the IUD was asymptomatic and she remained asymptomatic for a period of 8 years prior to presentation...
- Hemoglobin measurement prior to initiating copper intrauterine devices: a systematic reviewNaomi K Tepper
Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA
Contraception 87:639-44. 2013Women using copper intrauterine devices (IUDs) frequently experience bleeding abnormalities. This review was conducted to evaluate the evidence regarding whether hemoglobin levels should be measured prior to copper IUD insertion.
- [Summary of the practice guideline 'The intrauterine device' from the Dutch College of General Practitioners]Froukje S Boukes
Nederlands Huisartsen Genootschap, afd Richtlijnontwikkeling en Wetenschap, Utrecht, The Netherlands
Ned Tijdschr Geneeskd 153:A578. 2009..Therefore prior to insertion, the general practitioner should enquire about the risk of a SOA being present and, if necessary, perform SOA tests. In the Netherlands, IUD insertion can usually be performed at a general practice...
- Blood copper levels in Mexican users of the T380A IUDDolores De la Cruz
Unidad Universitaria de Investigación en Cariología University Cariology Research Unit, FES Zaragoza, Universidad Nacional Autonoma de Mexico, Mexico City, Mexico
Contraception 72:122-5. 2005..However, there are few reports of its systemic health effects. This study evaluates the association between the use of T380A IUD and blood Cu levels in a group of Mexican users...
- Association of age and parity with intrauterine device expulsionTessa Madden
Division of Clinical Research, Department of Obstetrics and Gynecology, Washington University in St Louis School of Medicine, St Louis, Missouri
Obstet Gynecol 124:718-26. 2014To investigate whether age 14 to 19 years and nulliparity are associated with expulsion of levonorgestrel and copper intrauterine devices (IUDs).
- Evaluation of endometrial steroid receptors and cell mitotic activity in women using copper intrauterine device: Can Cu-T prevent endometrial cancer?Kiran Guleria
Department of Obstetrics and Gynecology, University College of Medical Sciences and GTB Hospital, Delhi, India
J Obstet Gynaecol Res 30:181-7. 2004..e. cell mitosis and Ki67), endometrial steroid (estrogen and progesterone) receptors, and serum estradiol and progesterone level in women using copper intrauterine device (IUD) after 6 months of use...
- Development of a liquid chromatography-tandem mass spectrometry method for measuring plasma and uterine tissue levels of indomethacin in rabbits treated with indomethacin-medicated Cu-IUDsYouping Liu
Laboratory of Drug Metabolism and Pharmacokinetics, Shenyang Pharmaceutical University, Shenyang 110016, PR China
Contraception 85:419-24. 2012Some side effects of copper intrauterine devices (Cu-IUDs) including increased uterine bleeding, pelvic infections and pain have been reported...
- Levonorgestrel-releasing and copper intrauterine devices and the risk of breast cancerJürgen Dinger
ZEG Berlin Center for Epidemiology and Health Research, Germany
Contraception 83:211-7. 2011..This study compares the risk of breast cancer for levonorgestrel-releasing intrauterine devices (LNG(IUD)) versus copper IUDs (CU(IUD)) in women younger than 50 years of age...
- Safety of intrauterine contraceptive device (copper T 200 B) in women with cardiac diseaseVanita Suri
Department of Obstetrics and Gynecology, Post Graduate Institute of Medical Education and Research, Chandigarh 160012, India
Contraception 78:315-8. 2008..Women with cardiac disease are at increased risk for bacterial endocarditis. There is limited research regarding the use of intrauterine contraceptive devices (IUD) in women with cardiac disease...
- Effects of a progestogen-only pill (Exluton) and an intrauterine device (Multiload Cu250) on breastfeedingW Sinchai
Regional Health Promotion Center, Khon Khaen, Thailand
Adv Contracept 11:143-55. 1995..This study confirms that both Exluton and Multiload Cu250 are acceptable and safe contraceptive methods in breastfeeding women...
- Copper intrauterine devices in the management of secondary amenorrheaN Dubey
Lady Hardinge Medical College and Smt Sucheta Kriplani Hospital, New Delhi, India
Int J Gynaecol Obstet 95:159-60. 2006
- [Penetrated IUD as the cause of stricture in the sigmoid colon]Louise Schouborg Brinth
Hvidovre Hospital, Gastroenheden, Kirurgisk Sektion
Ugeskr Laeger 169:143-4. 2007..Laparotomy showed that the IUD had perforated the uterus and penetrated the sigmoid colon. Resection was performed. This case demonstrates the need to investigate every case of a missing IUD...
- Intrauterine devices and adolescentsMelanie A Gold
Division of Adolescent Medicine, Department of Pediatrics, University of Pittsburgh School of Medicine, PA 15213, USA
Curr Opin Obstet Gynecol 20:464-9. 2008..The purpose of this review is to inform the reader of new information published on intrauterine devices (IUDs) and adolescents...
- What is it about intrauterine devices that women find unacceptable? Factors that make women non-users: a qualitative studyClaire Asker
All Saints Medical Centre, Kings Heath, Birmingham, UK
J Fam Plann Reprod Health Care 32:89-94. 2006..This study explores how women's lay beliefs and perceptions about IUDs lead to rejection of this contraceptive choice...
- Copper T380A intrauterine device: lost and foundBliss Kaneshiro
Department of Obstetrics and Gynecology, University of Hawai i, Honolulu, HI 96826, USA
Hawaii Med J 67:131-2. 2008
- Contraceptive efficacy of an intra-uterine device in Brahman cattleG Fordyce
Department of Primary Industries, Queensland Beef Industry Institute, P O Box 976, Qld 4820, Charters Towers, Australia
Anim Reprod Sci 65:193-204. 2001....
- Tubal pathology: the role of hormonal contraception, intrauterine device use and Chlamydia trachomatis infectionGabriele S Merki-Feld
Department of Gynecology and Obstetrics, Endocrinology Clinic, University Hospital Zurich, Zurich, Switzerland
Gynecol Obstet Invest 63:114-20. 2007The aim of the present study was to identify a possible association between tubal pathology and the contraceptive methods previously used, especially third generation copper intrauterine devices (IUDs).
- [Modern intra-uterine contraception: a better option]J V Hamerlynck
Academisch Medisch Centrum, afd Verloskunde en Gynaecologie, Postbus 22 700, 1100 DE Amsterdam
Ned Tijdschr Geneeskd 145:1621-4. 2001....
- Insertion and removal of intrauterine devicesBrett Andrew Johnson
Methodist Charlton Medical Center, Dallas, Texas 75237, USA
Am Fam Physician 71:95-102. 2005..The IUD is inserted into the uterus according to individual protocols, with the threads cut at a length to allow the patient to check the device's position. Expulsion may occur with both types of IUDs...
- [Reasons for removal of intrauterine devices among women in general practice]Line Kolding
Kvindeafdelingen, Regionshospitalet Viborg, Heibergs Alle 4, 8800 Viborg, Denmark
Ugeskr Laeger 175:884-6. 2013..In general the women were satisfied with both types of IUDs. More women with copper-releasing IUDs had an early removal because of complaints than women with levonorgestrel-releasing IUDs...
- Pain from copper intrauterine device insertion: randomized trial of prophylactic ibuprofenDavid Hubacher
Family Health International, Research Triangle Park, NC, USA
Am J Obstet Gynecol 195:1272-7. 2006..This study was undertaken to determine whether 400 mg of prophylactic ibuprofen can alleviate pain from insertion of an intrauterine device (IUD) and to measure level of pain with improved techniques...
- Copper-T intrauterine device and levonorgestrel intrauterine system: biological bases of their mechanism of actionMaría Elena Ortiz
Instituto Chileno de Medicina Reproductiva, Postal code 6500970, Santiago, Chile
Contraception 75:S16-30. 2007..The common belief that the usual mechanism of action of IUDs in women is destruction of embryos in the uterus is not supported by empirical evidence...
- Combined oral contraceptive and intrauterine device use among women with gestational trophoblastic diseaseMary E Gaffield
Department of Reproductive Health and Research, World Health Organization, 1211 Geneva 27, Switzerland
Contraception 80:363-71. 2009..Women diagnosed with gestational trophoblastic disease (GTD) need safe and effective contraception because they are advised to delay a subsequent pregnancy...
- Copper T 380A IUD and magnetic resonance imagingMiriam Zieman
Department of Gynecology and Obstetrics, Emory University School of Medicine, Atlanta, GA 30303, USA
Contraception 75:93-5. 2007..Prior testing of the Copper T 380A intrauterine device (IUD) has been done using MR systems of 1.5 T or less. This study was performed to test this IUD in a MR system of 3.0 T...
- Reaching providers is not enough to increase IUD use: a factorial experiment of 'academic detailing' in KenyaJennifer Wesson
Family Health International, North Carolina, USA
J Biosoc Sci 40:69-82. 2008..However, the cost of the detailing in comparison to the small number of IUDs inserted indicates that this intervention is not cost-effective...
- Copper intrauterine device use by nulliparous women: review of side effectsDavid Hubacher
Family Health International, PO Box 13950, Research Triangle Park, NC 27709, USA
Contraception 75:S8-11. 2007..Nulliparity was once a relative contraindication to using the copper IUD. However, new research and changes in product labeling have eased safety concerns. Side effects remain a major problem with copper IUD use in this population...
- The acceptance rate of intrauterine contraceptive device (IUCD) amongst family planning clinic users in Lagos University Teaching Hospital (LUTH)O Adegbola
Department of Obstetrics and Gynaecology, College of Medicine, University of Lagos, Lagos University Teaching Hospital, Lagos
Nig Q J Hosp Med 18:175-80. 2008..Intrauterine Contraceptive Device is an effective reversible long-term contraceptive method that is popular and widely used in this environment...
- Do users of the intrauterine system (Mirena) have different genital symptoms and vaginal flora than users of the intrauterine contraceptive device?R Neale
Department of Genitourinary Medicine, Royal Cornwall Hospital NHS Trust, Truro, Cornwall TR1 3LJ, UK
Int J STD AIDS 20:423-4. 2009..More women with an IUCD developed BV compared with an IUS at 4-6 weeks and six months. However, there were insufficient numbers of women with BV to demonstrate any significant difference between the vaginal flora of the two groups...
- Effects of Mirena (levonorgestrel-releasing intrauterine system) and Ortho Gynae T380 intrauterine copper device on lipid metabolism--a randomized comparative studyYing Woo Ng
Department of Obstetrics and Gynaecology, National University Hospital, Singapore 119074, Singapore
Contraception 79:24-8. 2009..This study aims to assess the effects of levonorgestrel-releasing intrauterine system (LNG-IUS) on lipid metabolism in an Asian population using Ortho Gynae T380 copper containing (nonhormonal) intrauterine device (IUD) as a control...
- Contraception and HIV infection in womenOskari Heikinheimo
Department of Obstetrics and Gynaecology, University of Helsinki, Finland
Hum Reprod Update 15:165-76. 2009..This review aims to show the effect of contraceptive choices on risk of HIV and on the course of disease in women with HIV...
- Pyosalpinx caused by the tubal migration of an intrauterine device--a case reportSuna Ozdemir
Department of Gynaecology and Obstetrics, Meram Medical Faculty, Selcuk University, Konya, Turkey
Eur J Contracept Reprod Health Care 13:320-2. 2008..Tubal migration of an IUD is extremely rare and little is known about its mechanism. We describe a case of pyosalpinx caused by the tubal migration of a copper IUD. The tail of the device was embedded in the mesocolon...
- Effects of a copper-medicated intrauterine device on ovarian artery, uterine artery, and intrauterine blood flowO Shen
Department of Obstetrics and Gynecology, Shaare Zedek Medical Center, Jerusalem, Israel
Gynecol Obstet Invest 66:253-6. 2008..To determine the effect of a copper-medicated intrauterine device (IUD) on ovarian, uterine, arcuate, radial and subendometrial Doppler-derived indices of blood flow...
- Estrogen-progestogen once-a-month injectable contraceptives and serum prolactinJ Garza-Flores
Departamento de Biologia, Instituto Nacional de la Nutrición S Zubirán, Mexico City, Mexico
Contraception 39:519-29. 1989..Overall, the data demonstrated that the chronic administration of these estrogen/progestogen once-a-month injectable contraceptives does not affect the Prl baseline secretion in women...
- Unrecognised perforation of the uterus into bladder by an IUDA Honarbakhsh
Department of Radiology and Ultrasonography, Madaen Hospital, Tehran, Iran
J Obstet Gynaecol 23:444-5. 2003
- Can intrauterine contraceptive devices be a Candida albicans reservoir?Francieli Chassot
Division of Clinical Cytology, Teaching and Research in Clinical Analysis Laboratory, State University of Maringa, Maringa, Parana, Brazil
Contraception 77:355-9. 2008..The in vitro adherence of Candida albicans isolated from vaginal exudates of patients with vulvovaginal candidiasis (VVC) to intrauterine contraceptive devices (IUDs) and biofilm formation capacity were evaluated...
- The cost-effectiveness of long-acting reversible contraceptive methods in the UK: analysis based on a decision-analytic model developed for a National Institute for Health and Clinical Excellence (NICE) clinical practice guidelineI Mavranezouli
National Collaborating Centre for Women s and Children s Health NCC WCH, Royal College of Obstetricians and Gynaecologists, London, UK
Hum Reprod 23:1338-45. 2008..However, their uptake is low in much of the developed world. This study aimed at assessing the cost-effectiveness of LARC methods from the British National Health Service (NHS) perspective...
- Release behavior of cupric ions for TCu380A and TCu220C IUDsBianmei Cao
School of Materials Science and Engineering, University of Science and Technology Beijing, Beijing, People s Republic of China
Biomed Mater 3:044114. 2008..The main compounds identified were cuprite (Cu(2)O). Copper wire and copper tubes were implanted in the uteruses of rats. In vivo experiments were also done. The corrosion rate in vivo was higher than that in vitro...
- Late uterine perforation with an anchored IUD, the Gynefix: a case reportM Vekemans
Universite Libre de Bruxelles, Brussels, Belgium
Contraception 60:55-6. 1999..The incidence of this complication is unknown. The appropriateness or need of assessing echo-graphically the myometrial thickness before the insertion and of controlling its correct position after the insertion remains uncertain...
- Persistent subumbilical discharge associated with actinomycosis caused by intrauterine contraceptive device: a case reportIbrahim Polat
Gynecological Clinic, Istanbul Bakirkoy Woman and Children Hospital, Istanbul, Turkey
Arch Gynecol Obstet 277:457-60. 2008..We recommend consideration of this minor possibility during evaluation of women with chronic abdominal discharge...
- Transverse limb reduction and intrauterine device: case report and review of the literatureAlina Weissmann-Brenner
Helen Schneider Hospital for Women, Rabin Medical Center, Campus Beilinson, Petah Tiqva, Israel
Eur J Contracept Reprod Health Care 12:294-7. 2007..Pregnancies with an intrauterine device (IUD) in situ are associated with increased maternal and foetal morbidity and mortality. No proven teratogenetic effects have been attributed to IUDs...
- Magnetic resonance imaging appearances of the Mirena and GyneFix intra-uterine contraceptive devices: a report of two casesG H Hall
Centre for Magnetic Resonance Investigations, University of Hull at Hull Royal Infirmary, Hull, UK
Br J Fam Plann 26:224-6. 2000....
- Depot medroxyprogesterone acetate and basal serum prolactin levels in lactating womenS Ratchanon
Reproductive Medicine and Family Planning Units, Department of Obstetrics and Gynecology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
Obstet Gynecol 96:926-8. 2000..To study the effect of depot medroxyprogesterone acetate on basal serum prolactin levels in lactating women...
- Intrauterine device insertion during the postpartum period: a systematic reviewNathalie Kapp
Department of Reproductive Health and Research, World Health Organization, CH 1211 Geneva 27, Switzerland
Contraception 80:327-36. 2009..Insertion of an intrauterine device (IUD) at different times or by different routes during the postpartum period may increase the risk of complications...
- The intrauterine device in modern contraception: Still an actuality?Andrea Tinelli
Department of Obstetrics and Gynecology, Vito Fazzi Hospital, Lecce, Italy
Eur J Contracept Reprod Health Care 11:197-201. 2006....
- Uterine factors and risk of pregnancy in IUD users: a nested case-control studyAngels Avecilla-Palau
Centre d Atenció a la Salut Sexual i Reproductiva, Hospital Municipal de Badalona, Badalona Serveis Assistencials, C Mare de Déu de Lorda 119 125, 08915 Badalona, Spain
Contraception 67:235-9. 2003..The findings suggest that the gynecological characteristics of the woman analyzed should not be a criterion for the selection of potential IUD users...
- Intrauterine contraceptive devices and risk of pelvic inflammatory disease: standard of care in high STI prevalence settingsRichard Steen
Reprod Health Matters 12:136-43. 2004..Even with safe insertion, IUD promotion in areas of high STI/HIV prevalence must address women's needs for dual protection from infection and unwanted pregnancy...
- Prophylactic Ibuprofen: Effect on IUD Continuation RatesDavid Hubacher; Fiscal Year: 2003..In the US, ibuprofen may help spur renewed interest in the most cost effective and efficacious reversible contraceptive method available. ..
- PID IN IUD VS INJECTABLE CONTRACEPTIVE USERS PILOT STUDYPaul Feldblum; Fiscal Year: 2001..a randomized controlled trial comparing the incidence of pelvic inflammatory disease (PID) in users of copper intrauterine devices (IUDs) to the incidence in users of injectable depotmedroxyprogesterone acetate (DMPA)...
- ESTIMATING EFFICACY OF A MEDICAL INTERVENTIONJames Trussell; Fiscal Year: 2001....
- RCT of a Novel Oral Contraceptive Initiation MethodCarolyn Westhoff; Fiscal Year: 2004..We will also assess dual method use for STD prevention in the study to adoption of and adherence to oral contraceptives. We will also assess dual method use for STD prevention in the study population. ..
- Clinical Research in Human FertilityJoseph Stanford; Fiscal Year: 2005..Standford to develop his skills and gain the expertise needed to accomplish his goals. ..
- Obesity, Oral Contraception and Ovarian SuppressionCarolyn Westhoff; Fiscal Year: 2007..This study will have very good power to detect clinically important differences. Results could directly and immediately affect contraceptive practice. ..